AuditorJul 2, 2026, 04:38 PM
Praxis Precision Medicines Changes Auditors to KPMG
AI Summary
Praxis Precision Medicines, Inc. announced the dismissal of Ernst & Young LLP as its independent registered public accounting firm, effective June 29, 2026. The company confirmed that EY's reports for the fiscal years ended December 31, 2025, and 2024 did not contain any adverse opinions or disclaimers, and there were no disagreements on accounting or auditing matters. Concurrently, the Audit Committee approved the engagement of KPMG LLP as the new independent registered public accounting firm, also effective June 29, 2026.
Key Highlights
- Praxis Precision Medicines dismissed Ernst & Young LLP as its independent registered public accounting firm on June 29, 2026.
- The Audit Committee approved the dismissal of EY.
- EY's reports for fiscal years 2025 and 2024 did not contain adverse opinions or disclaimers.
- There were no disagreements with EY on accounting principles, financial statements, or auditing scope.
- Praxis Precision Medicines engaged KPMG LLP as its new independent registered public accounting firm on June 29, 2026.
- Neither the company nor KPMG consulted on accounting principles or audit opinions prior to engagement.
Price Impact
More from PRAX